Sharon Ayd is chief scientific officer and SVP, Pharmaceuticals at Regulatory Compliance Associates.
Impact of Non-Compliance on the American Healthcare Consumer
GMP non-compliance can spill over and impact patient access to life-saving medications.
Managing the Cost of Non-Compliance
Creating a quality culture can prevent the costs and challenges associated with receiving a consent decree.